Lyrica (pregabalin) is not FDA-approved for back pain, and the clinical evidence for using it this way is weak. While doctors sometimes prescribe it off-label for back pain that involves nerve irritation, major trials and meta-analyses have found it performs no better than placebo for most types of back pain, including sciatica.
That said, Lyrica does have a real role in treating certain kinds of nerve pain, which is why it comes up in conversations about back problems. Understanding the distinction between the types of pain it treats well and the types it doesn’t can save you time, side effects, and frustration.
What Lyrica Is Actually Approved For
The FDA has approved Lyrica for five specific conditions: nerve pain from diabetic neuropathy, nerve pain after shingles (postherpetic neuralgia), nerve pain from spinal cord injury, fibromyalgia, and as an add-on treatment for partial-onset seizures. Notice the pattern: most of these involve damaged or dysfunctional nerves sending pain signals when they shouldn’t be.
Back pain is notably absent from that list. In fact, “back pain” appears in the prescribing information only as a reported side effect during clinical trials, not as a condition the drug treats.
How Lyrica Works on Nerve Pain
Lyrica binds to a specific part of calcium channels on nerve cells called the alpha-2-delta subunit. Calcium flowing into nerve endings is what triggers the release of chemical signals that transmit pain. By attaching to these channels, Lyrica reduces calcium entry and dials down the overactive nerve signaling that characterizes neuropathic pain.
This mechanism explains both why it works for certain conditions and why it falls short for others. If your back pain comes from muscle strain, disc degeneration, or joint inflammation, Lyrica has no real target to act on. It’s designed for nerves that are misfiring, not for the inflammatory or mechanical causes behind most back pain.
What the Evidence Says About Back Pain
A meta-analysis published in The BMJ that included eight randomized controlled trials found that gabapentinoids (the drug class that includes both Lyrica and gabapentin) should not be used for chronic low back pain. In three of those studies, pregabalin actually performed worse at pain relief than other pain medications. The few studies that looked at improvements in physical function and emotional well-being found no meaningful benefits either. The drugs did, however, consistently increase the risk of dizziness compared to placebo or other treatments.
The evidence for sciatica is equally discouraging. A well-designed Australian trial enrolled patients with moderate to severe sciatica, defined as pain radiating below the knee with signs of nerve involvement like sensory loss or weakness. Patients received pregabalin ramped up to 300 mg twice daily or a matching placebo. At both eight weeks and one full year, there was no significant difference in pain, disability, back pain intensity, or quality of life between the two groups. The American Academy of Family Physicians rated this as strong evidence (Level 1b) that pregabalin does not relieve sciatica pain.
The One Back Pain Scenario Where It Has a Role
The exception is spinal cord injury. When the spinal cord itself is damaged, it can generate neuropathic pain that persists long after the original injury. This is one of Lyrica’s approved uses, and the mechanism makes sense: the cord’s nerve cells are misfiring, which is exactly what pregabalin targets.
Some doctors also prescribe Lyrica off-label when back pain clearly involves a neuropathic component, such as burning, shooting, or electric-shock sensations running down the leg. The reasoning is that even though clinical trials haven’t supported this use broadly, individual patients with a strong nerve-pain component might respond. This is a judgment call your prescriber makes based on your specific symptoms and what else you’ve tried.
How It Compares to Gabapentin
Gabapentin (Neurontin) works through the same mechanism and is prescribed for similar reasons. A comparative study of 360 patients with chronic lumbar radiculopathy found that pregabalin produced slightly better pain score reductions than gabapentin by the two-month mark. Both outperformed amitriptyline, an older antidepressant sometimes used for nerve pain. However, gabapentin caused fewer side effects and led to better long-term patient compliance. Neither drug produced dramatic results: average pain scores dropped from roughly 8.5 out of 10 to around 4.4 for pregabalin and 4.7 for gabapentin after two months.
Side Effects Worth Knowing About
Lyrica’s side effects are common enough that they factor into whether the drug is worth trying, especially for a condition where the evidence of benefit is limited. In clinical studies, 30% of adults experienced dizziness and 23% experienced drowsiness. About 9% of people gained at least 7% of their starting body weight during 14-week studies, compared to just 2% on placebo. That means someone weighing 180 pounds could gain 12 or more pounds in a few months.
Other frequently reported effects include blurry vision, trouble concentrating, swelling in the hands and feet, dry mouth, and a feeling of being “high.” The dizziness and drowsiness tend to be most noticeable when you first start the medication or increase the dose, but for some people they persist. These side effects become harder to justify when the expected benefit for your specific type of pain is small.
Why Doctors Still Prescribe It for Back Pain
If the evidence is this underwhelming, you might wonder why Lyrica comes up at all for back pain. Part of the answer is that chronic back pain is notoriously difficult to treat, and doctors cycle through available options when first-line treatments fail. Lyrica’s proven effectiveness for other nerve pain conditions creates a reasonable hypothesis that it might help the subset of back pain patients whose symptoms have a neuropathic quality. Another factor is that alternatives carry their own risks: long-term opioid use has well-known dangers, and anti-inflammatory drugs can cause stomach and kidney problems with extended use.
If your doctor has suggested Lyrica for back pain, it’s worth discussing what type of pain you’re experiencing. Dull, aching pain that worsens with movement points toward mechanical or inflammatory causes where Lyrica is unlikely to help. Burning, tingling, or shooting pain that follows a nerve path down your leg suggests a neuropathic component where there’s at least a theoretical basis for trying it, even though trial data hasn’t shown group-level benefits. A reasonable trial period is typically several weeks, with the understanding that if you’re not noticing improvement, continuing the medication means accepting side effects without a clear payoff.